Chantix raises suicide risks

Pfizer’s smoking cessation drug Chantix carries too many risks and should only be tried when other treatments fail, researchers said on Wednesday.

Chantix was eight times more likely to be linked with a reported case of suicidal behavior or depression than other nicotine replacement products, such as the nicotine patch, they said.

Enlace web: New study says Chantix raises suicide risks | Reuters.

 

Contenido seleccionado por Carlos Torrico Psicologo Leganes Madrid España para ePsicologia.eu

Publicado en Sin categoría y etiquetado , , , , , , , , , , , , , , , , , .